Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price hoisted by stock analysts at Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price suggests a potential upside of 20.29% from the […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) was upgraded by equities research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Wednesday, MarketBeat reports. The brokerage presently has a $48.00 target price on the stock, up from their prior target price of $36.00. Raymond James’ […]
Revolution Medicines (NASDAQ:RVMD) Coverage Initiated at Piper Sandler theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received an average rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued ratings on the stock in […]
Revolution Medicines (NASDAQ:RVMD) Price Target Increased to $42 00 by Analysts at Wedbush theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.